General Purpose Acquisition
GPAC · NASDAQ
About GPAC
- Employees
- 0
- Headquarters
- Millbrook, New York
- Listed
- Dec 3, 2025
- Sector
- N/A
- Industry
- N/A
GPAC key statistics
- Market cap
- 297.04M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 37.49K
- Volume
- 140.95K
- Open price
- $10.10
- High today
- $10.10
- Low today
- $10.10
- 52 Week high
- $10.12
- 52 Week low
- $9.86
General Purpose Acquisition (GPAC) at a glance
General Purpose Acquisition (GPAC) last traded at $10.10, with a market cap of 297.04M and a price-to-earnings ratio of 0.00.
Volume so far is 140.95K shares, above the average of 37.49K shares a day.
Over the past year General Purpose Acquisition has ranged from $9.86 to $10.12, and now sits 92% of the way up that range.
GPAC news
- Press releasePRNewswire
- Press releasePRNewswire
Usha Resources Congratulates Stardust Power on NASDAQ Listing, Provides Update on LOI to Sell Up to 90% of the Jackpot Lake Project for Total Consideration of up to US$26,025,000
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.